| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8683949 | Epilepsy & Behavior Case Reports | 2018 | 17 Pages |
Abstract
SGLT2 inhibitors may have a therapeutic value in SRSE patients who cannot achieve ketosis with KD alone.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Joseph R. Blunck, Joseph W. Newman, Ronald K. Fields, John E. Croom,